Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Dexamethasone, Dexmedetomidine, or Both After Laparoscopic Gallbladder Surgery

Official title: Effect of Dexamethasone, Dexmedetomidine and Their Combination on Postoperative Gastrointestinal Function Measured by I-FEED Score After Elective Laparoscopic Cholecystectomy Surgery: a Randomized Controlled Trial

Run by Benha University · NCT07329933 · Data updated 2026-11-12

This study tests whether dexamethasone, dexmedetomidine, or the combination help recovery of gut function after laparoscopic cholecystectomy.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment160 (estimated)
SponsorBenha University
Academic / other
Locations1 site (Banhā)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedMay 1, 2026
Study endsAugust 1, 2026
Registry record updatedJuly 20, 2026
Trial IDNCT07329933 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-65 with ASA I-II undergoing elective laparoscopic cholecystectomy who can consent.

Probably not a fit

Patients with certain allergies, GI motility disorders, chronic opioid/steroid/antiemetic use, significant cardiac disease, uncontrolled diabetes, pregnancy, morbid obesity, hepatic/renal dysfunction, or those undergoing emergency/open conversion may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants undergoing elective laparoscopic cholecystectomy are randomly assigned to receive dexamethasone, dexmedetomidine, both drugs, or placebo after anesthesia induction. The impact on postoperative gut function is measured with the I-FFED score. The study compares each active treatment to placebo to see if the drugs improve recovery of gastrointestinal function.

Why it matters

Potential benefit: If successful, this approach could speed up gut function recovery after gallbladder surgery and reduce symptoms like nausea and vomiting.

How similar studies have gone: Prior studies in perioperative care have explored these drugs individually for GI recovery, with varying success; this study adds a direct comparison including a combination approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* . Age 18-65 years.
* American Society of Anesthesiologists (ASA) physical status I or II.
* Scheduled for elective laparoscopic cholecystectomy surgery under general anesthesia.
* Ability to provide written informed consent

Exclusion Criteria:

* Known allergy or contraindication to any study drug (dexamethasone, dexmedetomidine, or placebo).
* Pre-existing gastrointestinal motility disorders (e.g., gastroparesis, inflammatory bowel disease).
* Chronic use of opioids, steroids, or antiemetics.
* History of severe cardiac disease (e.g., high-grade AV block, severe bradycardia).
* Uncontrolled diabetes mellitus (HbA1c \> 8.0%).
* Emergency surgery or conversion to open surgery.
* Pregnancy or breastfeeding.
* Morbid obesity (BMI \>40).
* Severe hepatic or renal dysfunction.

Where it's running

  • Benha University Hospital
    Banhā, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.